Page 30 - Acute Pancreatitis (Viêm tụy cấp)

References 916.e5

211. Rana SS, Bhasin DK, Sharma V, et al. Can early endoscopic ultra- 237. Vege SS, DiMagno MJ, Forsmark CE, et al. Initial medical treat-
sound predict pancreatic necrosis in acute pancreatitis? Ann For ment of acute pancreatitis: American gastroenterological association 58
2014;27:404–8. institute technical review. Gastroenterology 2018;154:1103–39.
212. Working Group IAPAPAAPG. IAP/APA evidence-based guide- 238. Akshintala VS, Hutfless SM, Yadav D, et al. A population-based
lines for the management of acute pancreatitis. Pancreatology study of severity in patients with acute on chronic pancreatitis. Pan-
2013;13:el–15. creas 2013;42:1245–50.
213. Wan J, Ouyang Y, Yu C, et al. Comparison of EUS with MRCP in 239. Alper E, Arabul M, Aslan F, et al. Radial EUS examination can be
idiopathic acute pancreatitis: a systematic review and meta-analysis. helpful in predicting the severity of acute biliary pancreatitis. Medi-
Gastrointest Endosc 2018;875:1180–8.e9. cine (Baltim) 2016;95:e2321.
214. Balthazar EJ, Freeny PC, van Sonnenberg E. Imaging and interven- 240. Anand G, Hutfless SM, Akshintala VS, et al. A population-based
tion in acute pancreatitis. Radiology 1994;193:297–306. evaluation of severity and mortality among transferred patients with
215. Uhl W, Roggo A, Kirschstein T, et al. Influence of contrast-en- acute pancreatitis. Pancreas 2014;43:1111–6.
hanced computed tomography on course and outcome in patients 241. Kumar S, Jalan A, Patowary BN, et al. To access the role of serum
with acute pancreatitis. Pancreas 2002;24:191–7. procalcitonin in predicting the severity of acute pancreatitis. Kath-
216. Carmen-Sanchez R, Uscanga L, Bezuary-Rivas P, et al. Potential mandu Univ 2017;15:19–24.
harmful effect of iodinated intravenous contrast medium on the clin- 242. Surbatovic M, Radakovic S. Tumor necrosis factor-alpha levels
ical course of mild acute pancreatitis. Arch Surg 2000;135:1280–4. early in severe acute pancreatitis: is there predictive value regarding
217. Balthazar EJ, Ranson JH, Naidich DP, et al. Acute pancreatitis: severity and outcome? J Clin Gastroenterol 2013;47:637–43.
prognostic value of CT. Radiology 1985;156:767–72. 243. Lupia E, Pigozzi L, Pivetta E, et al. Thrombopoietin as early bio-
218. Yadav AK, Sharma R, Kandasamy D, et al. Perfusion CT: can it pre- marker of disease severity in patients with acute pancreatitis. Pan-
dict the development of pancreatic necrosis in early stage of severe creas 2017;46:164–9.
acute pancreatitis? Abdom Imaging 2015;40:488–99. 244. Deng L, Wang L, Yong F, et al. Prediction of the severity of acute
219. Tsuji Y, Takahashi N, Isoda H, et al. Early diagnosis of pancreatic pancreatitis on admission by carboxypeptidase-B activation peptide:
necrosis based on perfusion CT to predict the severity of acute pan- a systematic review and meta-analysis. Clin Biochem 2015;48:740–6.
creatitis. J Gastroenterol 2017;52:1130–9. 245. Boskovic A, Pasic S, Soldatovic I, et al. The role of a D-dimer in
220. Tsuji Y, Takahashi N, Fletcher JG, et al. Subtraction color map of prediction of the course and outcome in pediatric acute pancreatitis.
contrast-enhanced and unenhanced CT for the prediction of pan- Pancreatology 2014;14:330–4.
creatic necrosis in early stage of acute pancreatitis. AJR Am J Roent- 246. Gomercic C, Gelsi E, Van Gysel D, et al. Assessment of D-dimers
genol 2014;202:W349–56. for the early prediction of complications in acute pancreatitis. Pan-
221. Arvanitakis M, Delhaye M, De Maertelaere V. Computed tomog- creas 2016;45:980–5.
raphy and magnetic resonance imaging in the assessment of acute 247. Chang CT, Liao HY, Huang WH, et al. Early prediction of severe
pancreatitis. Gastronenterology 2004;126:715–23. acute pancreatitis by urinary beta-2 microglobulin/saposin B peak
222. Moon JH, Cho YD, Cha SW, et al. The detection of bile duct stones ratios on MALDI-TOF. Clin Chim Acta 2015;440:115–22.
in suspected biliary pancreatitis: comparison of MRCP, ERCP, and 248. Arabul M, Celik M, Aslan O, et al. Hepcidin as a predictor of dis-
intraductal US. Am J Gastroenterol 2005;100:1051–7. ease severity in acute pancreatitis: a single center prospective study.
223. Haustein J, Niendorf HP, Krestin G, et al. Renal clearance of gad- Hepato-Gastroenterology 2013;60:595–600.
olinium-DTPA/dimeglumine in patients with chronic renal failure. 249. Huang J, Wu Z, Lu S, et al. Soluble B7-H2 as a novel marker
Invest Radiol 1992;27:153–6. in early evaluation of the severity of acute pancreatitis. Lab Med
224. Cananese C, Mereu MC, Aime S, et al. Gadolinium associated 2015;46:109–17.
nephrogenic systemic fibrosis: the need for nephrologists’ aware- 250. Isman FK, Zulfikaroglu B, Isbilen B, et al. Copeptin is a predic-
ness. J Nephrology 2008;21:324–36. tive biomarker of severity in acute pancreatitis. Am J Emerg Med
225. Anand G, Patel YA, Yeh HC, et al. Factors and outcomes associated 2013;31:690–2.
with MRCP use prior to ERCP in patients at high risk for choledo- 251. Park J, Chang JH, Park SH, et al. Interleukin-6 is associated with
cholithiasis. Can J Gastroenterol Hepatol 2016;2016:5132052. obesity, central fat distribution, and disease severity in patients with
226. Testoni PA, Mariani A, Curioni S, et al. MRCP-secretin test-guided acute pancreatitis. Pancreatology 2015;15:59–63.
management of idiopathic recurrent pancreatitis: long-term out- 252. Jia R, Tang M, Qiu L, et al. Increased interleukin-23/17 axis and
comes. Gastrointest Endosc 2007;143:165–9. C-reactive protein are associated with severity of acute pancreatitis
227. Petrov MS, Savides TJ. Systematic review of endoscopic ultraso- in patients. Pancreas 2015;44:321–5.
nography versus endoscopic retrograde cholangiopancreatography 253. Jin Y, Lin CJ, Dong LM, et al. Clinical significance of melato-
for suspected choledocholithiasis. Br J Surg 2009;96:967–74. nin concentrations in predicting the severity of acute pancreatitis.
228. Wilcox CM, Stahl R. Romancing the stone. Dig Endosc 2016; World J Gastroenterol 2013;19:4066–71.
28:16–8. 254. Karpavicius A, Dambrauskas Z, Gradauskas A, et al. The clinical
229. Tenner SM, Steinberg W. The admission serum lipase: amylase ra- value of adipokines in predicting the severity and outcome of acute
tio differentiates alcoholic from nonalcoholic acute pancreatitis. Am pancreatitis. BMC Gastroenterol 2016;16:99.
J Gastroenterol 1992;87:1755–8. 255. Khan J, Nordback I, Sand J. Serum lipid levels are associated with
230. King LG, Seelig CB, Ranney JE. The lipase to amylase ratio in the severity of acute pancreatitis. Digestion 2013;87:223–8.
acute pancreatitis. Am J Gastroenterol 1995;90:67–9. 256. Lei JJ, Zhou L, Liu Q, et al. Can mean platelet volume play a role in
231. Mariani A, Arcidiacono PG, Curioni S, et al. Diagnostic yield of evaluating the severity of acute pancreatitis? World J Gastroenterol
ERCP and secretin-enhanced MRCP and EUS in patients with 2017;23:2404–13.
acute recurrent pancreatitis of unknown aetiology. Dig Liver Dis 257. Lin J, Li Z, Zheng Y, et al. Elevated presepsin levels are associated
2009;41:753–8. with severity and prognosis of severe acute pancreatitis. Clin Lab
232. Tirkes T, Sandrasegaran K, Sanyal R, et al. Secretin-enhanced MR 2016;62:1699–708.
cholangiopancreatography: spectrum of findings. RadioGraphics 258. Lipinski M, Rydzewska-Rosolowska A, Rydzewski A, et al. Soluble
2013;33:1889–906. urokinase-type plasminogen activator receptor (suPAR) in patients
233. Rhodes M, Sussmann L, Cohen L, et al. Randomized trial of lapa- with acute pancreatitits (AP)- progress in prediction of AP sever-
roscopic exploration of common bile duct versus postoperative en- ity. Pancreatology 2017;17:24–9.
doscopic retrograde cholangiography for common bile duct stones. 259. Lipinski M, Rydzewska-Rosolowska A, Rydzewski A, et al. Uri-
Lancet 1998;351:159. nary neutrophil gelatinase-associated lipocalin as an early predic-
234. Kwong WT, Ondrejkova A, Vege SS. Predictors and outcomes of tor or disease severity and mortality in acute pancreatitis. Pancreas
moderately severe acute pancreatitis-evidence to reclassify. Pancre- 2015;44:448–52.
atology 2016;16:940–5. 260. Ma M, Zhai CX, Sun CX. Correlations between LP-PLA2 gene
235. Mounzer R, Langmead CJ, Wu BU, et al. Comparison of existing clin- polymorphisms and susceptibility and severity of acute pancreatitis in
ical scoring systems to predict persistent organ failure in patients with a Chinese population. Genet Test Mol Biomarkers 2017;21:206–12.
acute pancreatitis. Gastroenterology 2012;142:1476–82; quiz el 5–6. 261. Matas-Cobos AM, Redondo-Cerezo E, Alegria-Motte C, et al. The
236. Yang CJ, Chen J, Phillips AR, et al. Predictors of severe and critical role of toll-like receptor polymorphisms in acute pancreatitis occur-
acute pancreatitis: a systematic review. Dig Liver Dis 2014;46:446–51. rence and severity. Pancreas 2015;44:429–33.